Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by 3014704014 for the product Senna-doc (NDC 71309-113). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Active ingredients Purpose (in each tablet) Purpose
Docusate sodium 50 mg.......................................Stool softner
Sennosides 8.6 mg................................................Laxative
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
take preferably at bedtime or as directed by a doctor
croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide
Call toll free 1-844-384-3723 Monday through Friday 9AM – 5PM EST or www.safrelpharma.com
* Please review the disclaimer below.